A meta-analysis of 2156 patients concluded that the detection of Kras mutations in pancreatic exocrine secretions did not provide sufficient specificity nor sensitivity to distinguish PDAC patients from chronic pancreatitis or pre-malignant lesions, or healthy individuals [241]. This evidence concerns the gene KRAS and chronic pancreatitis.